Oak Street Health (OSH) PT Lowered to $48 at Cowen

Cowen analyst Gary Taylor lowered the price target on Oak Street Health (NYSE: OSH) to $48.00 (from $61.00) while maintaining an Outperform rating.

The analyst commented, "We are updating our OSH model following 3Q21 results, after giving due consideration for an acceleration of ratable center openings in 2022 to as many as 65 new centers. In addition, we expect management to guide 2022 conservatively in January without assuming a full sequential recovery of the greater than $100m of COVID/utilization/2021 cohort headwinds."

You May Also Be Interested In

• CrowdStrike (CRWD) PT Raised to $235 at TD Cowen
• Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)